RPS supports introduction of disclosure of pharma payments register for health professionals
June 20 2016
The Royal Pharmaceutical Society has supported steps being taken to introduce a register disclosing payments being made by the pharmaceutical industry to health professionals.
Disclosure of payments will be made public on a register set up by the Association of the British Pharmaceutical Industry, to be launched on June 30. As part of a European-wide initiative to increase transparency, the UK database will publish ‘transfers of value’ from its members to healthcare professionals and organisations.
The database will record:
• event registration fees
• event travel and accommodation costs
• fees and expenses for consultancy or services
• payments for research and development activities
• payments for activities such as sponsorship of programmes and initiatives.
Initially, available data will relate to 2015, but the database will be updated on an ongoing basis.
RPS President Ash Soni said: “I strongly support greater transparency around payments made by the pharmaceutical industry to health professionals and healthcare organisations. This new database is a step in the journey towards greater openness and accountability in the relationships between industry and the health professions.
“Collaboration with the pharmaceutical industry is essential to driving innovation in medicines. It is important it’s fully understood that working with industry ultimately helps drive patient care. Lack of transparency and understanding contributes to lack of confidence in the healthcare professions and their interaction with industry.”
Mr Soni has urged pharmacists to participate in this initiative “and allow disclosure to further build the trust between us and our patients.”